211 related articles for article (PubMed ID: 17129610)
1. Experimentally induced aggressiveness in heroin-dependent patients treated with buprenorphine: comparison of patients receiving methadone and healthy subjects.
Gerra G; Zaimovic A; Raggi MA; Moi G; Branchi B; Moroni M; Brambilla F
Psychiatry Res; 2007 Jan; 149(1-3):201-13. PubMed ID: 17129610
[TBL] [Abstract][Full Text] [Related]
2. Aggressive responding in abstinent heroin addicts: neuroendocrine and personality correlates.
Gerra G; Zaimovic A; Moi G; Bussandri M; Bubici C; Mossini M; Raggi MA; Brambilla F
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):129-39. PubMed ID: 14687867
[TBL] [Abstract][Full Text] [Related]
3. Aggressive responding of male heroin addicts under methadone treatment: psychometric and neuroendocrine correlates.
Gerra G; Zaimovic A; Raggi MA; Giusti F; Delsignore R; Bertacca S; Brambilla F
Drug Alcohol Depend; 2001 Dec; 65(1):85-95. PubMed ID: 11714593
[TBL] [Abstract][Full Text] [Related]
4. Experimentally induced aggressive behavior in subjects with 3,4-methylenedioxy-methamphetamine ("Ecstasy") use history: psychobiological correlates.
Gerra G; Zaimovic A; Ampollini R; Giusti F; Delsignore R; Raggi MA; Laviola G; Macchia T; Brambilla F
J Subst Abuse; 2001; 13(4):471-91. PubMed ID: 11775077
[TBL] [Abstract][Full Text] [Related]
5. Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence.
Kakko J; von Wachenfeldt J; Svanborg KD; Lidström J; Barr CS; Heilig M
Biol Psychiatry; 2008 Jan; 63(2):172-7. PubMed ID: 17850768
[TBL] [Abstract][Full Text] [Related]
6. HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.
Lott DC; Strain EC; Brooner RK; Bigelow GE; Johnson RE
J Subst Abuse Treat; 2006 Sep; 31(2):187-94. PubMed ID: 16919747
[TBL] [Abstract][Full Text] [Related]
7. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
[TBL] [Abstract][Full Text] [Related]
8. Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study.
Gerra G; Leonardi C; D'Amore A; Strepparola G; Fagetti R; Assi C; Zaimovic A; Lucchini A
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):265-72. PubMed ID: 16309810
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome.
Gerra G; Borella F; Zaimovic A; Moi G; Bussandri M; Bubici C; Bertacca S
Drug Alcohol Depend; 2004 Jul; 75(1):37-45. PubMed ID: 15225887
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ
Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341
[TBL] [Abstract][Full Text] [Related]
11. Rapid detoxification of heroin dependence by buprenorphine.
Liu ZM; Cai ZJ; Wang XP; Ge Y; Li CM
Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):112-4. PubMed ID: 10072959
[TBL] [Abstract][Full Text] [Related]
12. Relationship of personality traits and drug of choice by cocaine addicts and heroin addicts.
Gerra G; Bertacca S; Zaimovic A; Pirani M; Branchi B; Ferri M
Subst Use Misuse; 2008; 43(3-4):317-30. PubMed ID: 18365934
[TBL] [Abstract][Full Text] [Related]
13. Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial.
Soyka M; Lieb M; Kagerer S; Zingg C; Koller G; Lehnert P; Limmer C; Kuefner H; Hennig-Fast K
J Clin Psychopharmacol; 2008 Dec; 28(6):699-703. PubMed ID: 19011441
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
[TBL] [Abstract][Full Text] [Related]
15. Consensus statement on office-based treatment of opioid dependence using buprenorphine.
Fiellin DA; Kleber H; Trumble-Hejduk JG; McLellan AT; Kosten TR
J Subst Abuse Treat; 2004 Sep; 27(2):153-9. PubMed ID: 15450648
[TBL] [Abstract][Full Text] [Related]
16. Quality of life among heroin users on buprenorphine versus methadone maintenance.
Ponizovsky AM; Grinshpoon A
Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
[TBL] [Abstract][Full Text] [Related]
17. Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment.
Quaglio G; Lugoboni F; Pattaro C; Melara B; ; Mezzelani P; Des Jarlais DC;
Drug Alcohol Depend; 2008 Apr; 94(1-3):12-8. PubMed ID: 18083312
[TBL] [Abstract][Full Text] [Related]
18. Role of buprenorphine in the management of heroin addiction.
Sung S; Conry JM
Ann Pharmacother; 2006 Mar; 40(3):501-5. PubMed ID: 16434562
[TBL] [Abstract][Full Text] [Related]
19. Induction of patients with moderately severe methadone dependence onto buprenorphine.
Glasper A; Reed LJ; de Wet CJ; Gossop M; Bearn J
Addict Biol; 2005 Jun; 10(2):149-55. PubMed ID: 16191667
[TBL] [Abstract][Full Text] [Related]
20. Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients.
Walter M; Wiesbeck GA; Degen B; Albrich J; Oppel M; Schulz A; Schächinger H; Dürsteler-MacFarland KM
Addict Biol; 2011 Jan; 16(1):145-51. PubMed ID: 20331562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
